Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Oncogene|September 1, 1994
Interaction of p53 with MDM2 is independent of E6 and does not mediate wild type transformation suppressor functionN J Marston, T Crook, K H VousdenOncogene|May 4, 1995
Oligomerisation of full length p53 contributes to the interaction with mdm2 but not HPV E6N J Marston, J R Jenkins, K H VousdenOncogene|July 22, 1998
Activation of p53 DNA binding activity by point mutationN J Marston, R L Ludwig, K H VousdenCell|December 2, 1994
Transcriptional activation by p53 correlates with suppression of growth but not transformationT Crook, N J Marston, E A Sara, et al.Virology|March 1, 1996
Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6T Crook, R L Ludwig, N J Marston, et al.Molecular and Cellular Biology|June 22, 1999
Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammalsN J Marston, W J Richards, D Hughes, et al.British Journal of Cancer|July 1, 1993
Biodistribution and tumour localisation of 131I SWA11 recognising the cluster w4 antigen in patients with small cell lung cancerJ A Ledermann, N J Marston, R A Stahel, et al.Cancer Research|January 4, 1998
Nuclear location and cell cycle regulation of the BRCA2 proteinD Bertwistle, S Swift, N J Marston, et al.British Journal of Cancer|February 1, 1994
The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodiesY Olabiran, J A Ledermann, N J Marston, et al.Pageof 1